120 related articles for article (PubMed ID: 25318639)
1. First evidence of long term safety of human embryonic stem cells is reported.
Wise J
BMJ; 2014 Oct; 349():g6248. PubMed ID: 25318639
[No Abstract] [Full Text] [Related]
2. Long-term safety and function of RPE from human embryonic stem cells in preclinical models of macular degeneration.
Lu B; Malcuit C; Wang S; Girman S; Francis P; Lemieux L; Lanza R; Lund R
Stem Cells; 2009 Sep; 27(9):2126-35. PubMed ID: 19521979
[TBL] [Abstract][Full Text] [Related]
3. Embryonic stem cell implantation for the treatment of Stargardt’s disease and macular degeneration.
Regen Med; 2011 Sep; 6(5):539-40. PubMed ID: 21916588
[No Abstract] [Full Text] [Related]
4. Embryonic stem cells as a treatment for macular degeneration.
Pan CK; Heilweil G; Lanza R; Schwartz SD
Expert Opin Biol Ther; 2013 Aug; 13(8):1125-33. PubMed ID: 23705996
[TBL] [Abstract][Full Text] [Related]
5. [Retinal cell therapy using iPS cells].
Takahashi M
Rinsho Shinkeigaku; 2013; 53(11):1016. PubMed ID: 24291864
[No Abstract] [Full Text] [Related]
6. Stem Cell Treatment for Age-Related Macular Degeneration: the Challenges.
Singh MS; MacLaren RE
Invest Ophthalmol Vis Sci; 2018 Mar; 59(4):AMD78-AMD82. PubMed ID: 30025109
[No Abstract] [Full Text] [Related]
7. Present and future of stem cells for cardiovascular therapy.
Sánchez PL; Villa A; Sanz R; Domínguez M; Ludwig I; Fernández ME; Fernández-Avilés F
Ann Med; 2007; 39(6):412-27. PubMed ID: 17852037
[TBL] [Abstract][Full Text] [Related]
8. Human embryonic stem cell: is it a realistic cell source for regenerative therapy of heart failure?
Pucéat M
Pathol Biol (Paris); 2008 Mar; 56(2):47-9. PubMed ID: 18178334
[No Abstract] [Full Text] [Related]
9. An eye to the future: Researchers debate best path for stem cell-derived therapies.
Chakradhar S
Nat Med; 2016 Feb; 22(2):116-9. PubMed ID: 26845400
[No Abstract] [Full Text] [Related]
10. Human embryonic stem cells: early hints on safety and efficacy.
Atala A
Lancet; 2012 Feb; 379(9817):689-90. PubMed ID: 22281387
[No Abstract] [Full Text] [Related]
11. Clinical Translation of Pluripotent Stem Cell Therapies: Challenges and Considerations.
Desgres M; Menasché P
Cell Stem Cell; 2019 Nov; 25(5):594-606. PubMed ID: 31703770
[TBL] [Abstract][Full Text] [Related]
12. Good practice.
Nature; 2014 Jun; 510(7504):187-8. PubMed ID: 24926498
[No Abstract] [Full Text] [Related]
13. Embryonic stem-cell-derived retinal pigment epithelial cells for macular degeneration.
Falsini B; Bisti S
Lancet; 2012 Jun; 379(9831):2050; author reply 2050-1. PubMed ID: 22656882
[No Abstract] [Full Text] [Related]
14. Embryonic stem-cell-derived retinal pigment epithelial cells for macular degeneration.
Huang J; McAlinden C; Wang Q; Jin ZB; Pesudovs K
Lancet; 2012 Jun; 379(9831):2050; author reply 2050-1. PubMed ID: 22656881
[No Abstract] [Full Text] [Related]
15. Embryonic stem cell therapy.
Goswami J; Rao M
IDrugs; 2007 Oct; 10(10):713-9. PubMed ID: 17899490
[TBL] [Abstract][Full Text] [Related]
16. Stem cell therapy clears first hurdle in AMD.
Sheridan C
Nat Biotechnol; 2014 Dec; 32(12):1173-4. PubMed ID: 25489818
[No Abstract] [Full Text] [Related]
17. Moorfields Eye Hospital is to host European trial of human embryonic stem cells.
Watts G
BMJ; 2011 Sep; 343():d6124. PubMed ID: 21948878
[No Abstract] [Full Text] [Related]
18. Stem Cell Implants for Age-Related Macular Degeneration.
Abbasi J
JAMA; 2018 Jun; 319(22):2263. PubMed ID: 29896614
[No Abstract] [Full Text] [Related]
19. Adapting Preclinical Benchmarks for First-in-Human Trials of Human Embryonic Stem Cell-Based Therapies.
Barazzetti G; Hurst SA; Mauron A
Stem Cells Transl Med; 2016 Aug; 5(8):1058-66. PubMed ID: 27334488
[TBL] [Abstract][Full Text] [Related]
20. Stem cell-based treatment in geographic atrophy: promises and pitfalls.
Kvanta A; Grudzinska MK
Acta Ophthalmol; 2014 Feb; 92(1):21-6. PubMed ID: 23890249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
